161 related articles for article (PubMed ID: 11352401)
1. Expression of p185 and p53 in benign and malignant colorectal lesions.
Porcelli B; Frosi B; Terzuoli L; Arezzini L; Marinello E; Vernillo R; De Martino A; Vatti R; Minacci C
Histochem J; 2001 Jan; 33(1):51-7. PubMed ID: 11352401
[TBL] [Abstract][Full Text] [Related]
2. [Detection of the expression of P21, P53, P185 proteins and the mutation of ras, p53 genes in colorectal adenoma and carcinoma].
Liang Z; Liu F; Luo Y
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):352-5. PubMed ID: 8732090
[TBL] [Abstract][Full Text] [Related]
3. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
4. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.
Kapitanović S; Radosević S; Kapitanović M; Andelinović S; Ferencić Z; Tavassoli M; Primorać D; Sonicki Z; Spaventi S; Pavelic K; Spaventi R
Gastroenterology; 1997 Apr; 112(4):1103-13. PubMed ID: 9097992
[TBL] [Abstract][Full Text] [Related]
5. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
Einspahr JG; Martinez ME; Jiang R; Hsu CH; Rashid A; Bhattacharrya AK; Ahnen DJ; Jacobs ET; Houlihan PS; Webb CR; Alberts DS; Hamilton SR
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1443-50. PubMed ID: 16896030
[TBL] [Abstract][Full Text] [Related]
6. Determination of p185 and adenylosuccinate lyase (ASL) activity in preneoplastic colon lesions and intestinal mucosa of human subjects.
Terzuoli L; Carlucci F; Martino AD; Frosi B; Porcelli B; Minacci C; Vernillo R; Baldi L; Marinello E; Pagani R; Tabucchi A
Clin Biochem; 1998 Oct; 31(7):523-8. PubMed ID: 9812171
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
[TBL] [Abstract][Full Text] [Related]
8. [The significance of p53 gene mutations and expressions in human colorectal tumors].
Qian H; Yu B; Zhou X
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetics, p53 and bcl-2 expression, and c-Ki-ras mutations in flat-elevated tubulovillous adenomas and adenocarcinomas of the colorectum: comparison with polypoid lesions.
Sada M; Mitomi H; Igarashi M; Katsumata T; Saigenji K; Okayasu I
Scand J Gastroenterol; 1999 Aug; 34(8):798-807. PubMed ID: 10499481
[TBL] [Abstract][Full Text] [Related]
10. Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma.
Sekine S; Ogawa R; Oshiro T; Kanemitsu Y; Taniguchi H; Kushima R; Kanai Y
Genes Chromosomes Cancer; 2014 Apr; 53(4):366-72. PubMed ID: 24470207
[TBL] [Abstract][Full Text] [Related]
11. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
12. Mutation of p53 tumor suppressor gene in flat neoplastic lesions of the colorectal mucosa.
Rubio CA; Rodensjö M
Dis Colon Rectum; 1996 Feb; 39(2):143-7. PubMed ID: 8620779
[TBL] [Abstract][Full Text] [Related]
13. High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters.
Kapitanovic S; Spaventi R; Poljak L; Kapitanovic M; Pavelic ZP; Gluckman JL; Spaventi S; Pavelic K
Cancer Detect Prev; 1994; 18(2):97-101. PubMed ID: 7912991
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.
Yasui W; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
Virchows Arch; 1996 Sep; 429(1):13-9. PubMed ID: 8865848
[TBL] [Abstract][Full Text] [Related]
15. Frequent activating GNAS mutations in villous adenoma of the colorectum.
Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.
Ieda S; Watatani M; Yoshida T; Kuroda K; Inui H; Yasutomi M
Surg Today; 1996; 26(4):230-5. PubMed ID: 8727942
[TBL] [Abstract][Full Text] [Related]
20. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
Yao T; Kouzuki T; Kajiwara M; Matsui N; Oya M; Tsuneyoshi M
J Pathol; 1999 Apr; 187(5):511-7. PubMed ID: 10398114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
